Medidata Earns Everest Group's Top Luminary Ranking as Clinical AI Platform Expands Oncology and Site Partnerships
SHERIDAN, WYOMING - April 14, 2026 - Medidata Solutions has received the top "Luminary" placement in Everest Group's 2026 review of life sciences technology platforms, with the assessment citing the company's market performance, partnership portfolio, and AI solution maturity. The recognition arrives alongside two concrete partnership expansions: a deepened agreement with The Menarini Group to deploy Medidata's Study Build AI technology across a global oncology pipeline, and a new integration with CRIO connecting more than 2,500 research sites worldwide. Together, these developments mark a period of deliberate platform consolidation and AI-scale deployment for one of the most broadly deployed clinical data infrastructure providers in the life sciences sector.